Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Osteosarcoma 2Rhabdomyosarcoma 1Neuroblastoma 1Neoplasms 1Melanoma 1Hodgkin Disease 1Hepatoblastoma 1Glioblastoma 1Fibrolamellar hepatocellular carcinoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Flow Cytometry 5Therapeutics 4Psychiatric Rehabilitation 4Cyclophosphamide 4Radiotherapy 3Polymerase Chain Reaction 3Melphalan 3Amplified Fragment Length Polymorphism Analysis 3sargramostim 2liposomal amphotericin B 2Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Methylprednisolone 2Itraconazole 2Ipilimumab 2Immunologic Techniques 2Filgrastim 2Fentanyl 2Early Intervention, Educational 2Dexamethasone 2Caspofungin 2Calcium Dobesilate 2CTLA-4 Antigen 2Aprepitant 2Alemtuzumab 2thymoglobulin 1tazemetostat 1imetelstat 1dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × dostarlimab × CNS × Clear all
NCT06521567 2025-11-12

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

GlaxoSmithKline

Phase 1/2 Active not recruiting
83 enrolled
CNSDermatologicGastrointestinalLymphoidSarcoma

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡